Sirnaomics

ANSWERING UNIQUE FACILITY NEEDS MOVES SIRNAOMICS FORWARD

Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company discovering and developing innovative drugs for treatments in cancer, fibrosis, medical aesthetics, and antivirals. The challenge: With 16 clinical trials currently underway, the company needed a new headquarters and lab that would accommodate the company’s unique operational needs for a higher-than-average chemical fume density, a small animal vivarium, and the use of disposable technology. The solution: VaLogic’s Owner’s Representation service to shepherd the project from capital budget to completion.

Accountability, achievement, and a celebration.

For the fit-out of Sirnaomics’ and RNA Immune’s new facility in Germantown, MD, VaLogic worked closely with the design team and contractors, developing a comprehensive capital budget assuring accountability and measurability, as well as a project schedule. The estimated timeline of fourteen months was achieved and, on Sirnaomics’ 15th anniversary, the company held the grand opening ceremony for the facility.